Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to screen the optimal intervention strategies to rapid establish the protective barriers against HIV-infection by maximally decreasing the viremia among HIV- infected patients.


Clinical Trial Description

Sexual transmission became the primary route of HIV transmission in China and heterosexual transmission also contributed greatly to HIV epidemic which was mostly reported in South-west rural areas. In past years, Yunnan has experienced powerful campaign of scaling-up the HIV identification as well as antrertroviral therapy.

This study will investigate how to reach the last two of HIV'90-90-90 targets': to provide antiretroviral therapy (ART) for 90% of who diagnosed HIV infection and to achieve viral suppression for 90% of those treated.

The study population consists of participants who received an newly diagnosed HIV infection within the study period. All rerolled participants will be randomized into different study group. In intervention group, medical institutions will provide patients personal involved intervention strategies which guided by frequent viral load detection, and providing of the dosage form of 400 mg EFV in their antiviral therapy.

Main assessment measures are viral suppression rate of HIV-infected patients and treatment coverage . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03852849
Study type Interventional
Source National Center for AIDS/STD Control and Prevention, China CDC
Contact Zhao Yan, PHD
Phone +86-10-5338-0980
Email zhaoyan@chinaaids.cn
Status Not yet recruiting
Phase N/A
Start date March 1, 2019
Completion date March 1, 2021